Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

smoldering plasma cell myeloma - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

smoldering plasma cell myeloma

MONDO:0005235

Also known as:asymptomatic myelomaasymptomatic plasma cell myelomasmoldering Multiple myeloma/plasma cell myeloma

Find Clinical TrialsTrials

Overview

A plasma cell myeloma lacking clinical manifestations and organ impairment.

Clinical Trials58 registered · 26 recruiting

Diagnosis

Biomarker and diagnostic research for smoldering plasma cell myeloma has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

58 clinical trials registered, 26 recruiting. Interventions under study include other interventions, drug therapy, biologic therapy, and procedural interventions. Pipeline includes 6 PHASE3, 21 PHASE2, 3 PHASE1. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT05841550](https://clinicaltrials.gov/study/NCT05841550)

Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 3:00 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 58 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Research summaries	38	46%
Laboratory research	16	20%
Clinical study results	9	11%
Testing and diagnosis research	7	9%
Other research	5	6%
Disease patterns and progression	5	6%
Patient case studies	1	1%
New treatment approaches	1	1%

Kisho

smoldering plasma cell myeloma

Overview

Diagnosis

Research Landscape

Medical References

Questions for Your Care Team

Questions for Your Care Team

Recent Publications

Latest News & Developments

Hyperviscosity Syndrome as a Rare Presentation of Immunoglobulin G Kappa Smoldering Multiple Myeloma Successfully Treated With Daratumumab.

smoldering plasma cell myeloma

Overview

Diagnosis

Research Landscape

Medical References

Subtypes

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications

Latest News & Developments

Hyperviscosity Syndrome as a Rare Presentation of Immunoglobulin G Kappa Smoldering Multiple Myeloma Successfully Treated With Daratumumab.